Improvement of cardiovascular outcomes in patients with advanced research hub

TRACK - Treatment of cardiovascular disease with low dose Rivaroxaban in Advanced CKD.

The TRACK study tests whether a low-dose blood-thinning tablet called rivaroxaban can help protect people with advanced kidney disease from heart attacks, strokes, and circulation problems. Half of the participants take rivaroxaban, while the other half take a dummy tablet (placebo) to see if the medicine is safe and effective.